Skip to main content

Hepatitis B in Malaysia: Symptoms, Testing, Treatment & Vaccine

Hepatitis B is a sexually and blood-borne viral infection (sometimes grouped under STDs) that can become chronic and cause cirrhosis or liver cancer. Around 1 million Malaysians live with chronic HBV. The 3-dose vaccine is over 95% effective. Testing is by blood serology (HBsAg, anti-HBs, anti-HBc).

Book a confidential appointment

Medically reviewed by · MBChB, MMC-registered · Pathogen: Hepatitis B virus (HBV) · ICD-10 B16, B18.0, B18.1

Amber resin droplet on dark slate - hepatitis B liver care, vaccination and monitoring.

What is hepatitis b?

Hepatitis B is a viral infection of the liver that ranges from a brief acute illness to a lifelong chronic infection. Around 5% of adults who acquire HBV develop chronic infection (much higher in infants - up to 90% if infected at birth).

Chronic HBV is the leading cause of liver cancer in Malaysia and a major cause of cirrhosis. Effective antivirals control viral replication but rarely eradicate the virus.

Pathogen: Hepatitis B virus (HBV) (Enveloped DNA virus, Hepadnaviridae).

How it spreads

  • Unprotected vaginal, anal or oral sex
  • Mother-to-baby during birth (vertical transmission - the most common route in endemic regions)
  • Sharing needles, syringes, razors or toothbrushes
  • Blood transfusion (screened in Malaysia since 1980s)
  • Tattoo, piercing or acupuncture with unsterilised equipment
  • Household contact via shared personal items - rare but documented

Who is at risk? Should I get tested?

  • Born to a mother with chronic HBV
  • Healthcare workers (occupational exposure)
  • Men who have sex with men
  • People who inject drugs
  • Multiple sexual partners
  • People living in or born in endemic regions
  • Household and sexual contacts of someone with chronic HBV
  • Patients on dialysis or receiving frequent blood products

Should I get tested? Quick self-check

Answer the questions below - your concierge can advise on the next step.

  • Were you born before 1989 (before universal HBV vaccination in Malaysia)?
  • Was your mother known to have hepatitis B?
  • Have you ever had an unprotected sexual partner with hepatitis B?
  • Have you had a tattoo, piercing or medical procedure with shared equipment?
  • Have you ever injected drugs or shared injection equipment?
  • Do you have unexplained fatigue, jaundice, or abnormal liver tests?

Symptoms

  • Most acute HBV infections in adults are mild or symptom-free
  • Fatigue, loss of appetite, nausea, abdominal discomfort
  • Jaundice (yellow skin and eyes)
  • Dark urine, pale stools
  • Joint pain
  • Chronic HBV is usually silent until late-stage cirrhosis or liver cancer develops

Asymptomatic in men

Around 50-70% of acute adult HBV infections cause no symptoms; chronic HBV is silent for years to decades

Asymptomatic in women

Same as men; pregnant women may first discover HBV at antenatal screening

Source: see reference [1] below.

Malaysia statistics

Estimated Malaysians living with chronic HBV~1.0-1.5 million (3-5% of population)[2]
Hepatitis B is the leading cause of hepatocellular carcinoma in Malaysia[2]
Universal infant HBV vaccination introduced in Malaysia1989 - coverage now >95%[3]
Vertical (mother-to-child) transmission risk without prophylaxisUp to 90% in HBeAg-positive mothers[1]
Effectiveness of HBV vaccine (3-dose course, healthy adults)>95%[1]

Testing & window period

Method

Serology panel: HBsAg (current infection), anti-HBs (immunity/vaccination), anti-HBc (past or current exposure). HBV DNA viral load if positive.

Specimen

Venous blood

Window period

HBsAg detectable 4-10 weeks post-exposure. Repeat at 3 and 6 months if first test negative and recent exposure.

Retest

Anti-HBs titre 1-2 months after vaccination course to confirm seroprotection (>10 mIU/mL). Chronic HBV requires 6-monthly viral load and liver imaging.

Treatment

First-line: Acute HBV: supportive care; most healthy adults clear the virus without antiviral medication. Chronic HBV with active replication: long-term oral antiviral therapy to suppress viral replication, prescribed by our medical team in co-management with a hepatologist.

Alternative: Injectable immune-modulating therapy is offered to selected patients (typically younger, with low viral load) under specialist care.

Partner management: Test partners and household contacts. Offer vaccination to all unvaccinated contacts.

Chronic HBV care is shared between Hisential and a hepatologist for liver monitoring and cancer surveillance.

Follow-up

  • Chronic HBV: 6-monthly viral load, liver function and alpha-fetoprotein with liver ultrasound for cancer surveillance
  • Post-exposure prophylaxis: HBV vaccine + hepatitis B immunoglobulin (HBIG) within 24-72 hours if non-immune contact
  • Annual review of suppression therapy
  • Pregnancy: maternal antiviral if high viral load to reduce vertical transmission

Prevention

  • 3-dose HBV vaccine - the single most effective measure (>95% protection)
  • Universal infant immunisation in Malaysia since 1989
  • Catch-up vaccination for unvaccinated adults
  • Consistent condom use
  • Never share needles, razors, toothbrushes
  • Birth-dose HBV vaccine + HBIG for all babies born to HBsAg-positive mothers
  • Hepatitis A vaccine recommended for MSM and people with chronic HBV/HCV

Vaccination

The HBV vaccine is given as 3 doses (0, 1, 6 months) and produces protective immunity in over 95% of healthy adults. It is universal for Malaysian infants and recommended for any unvaccinated adult, particularly MSM, healthcare workers, dialysis patients, and household/sexual contacts of HBV-positive individuals.

See also: STI & hepatitis testing, Vaccination consultation

FAQ

Hepatitis B - frequently asked questions

Clear answers, written by our clinical team. Tap any question for its direct permalink, or reach out to your Personal Concierge for anything else.

  1. If I was vaccinated as a baby, am I still protected?

    Yes, in the vast majority of cases. The HBV vaccine produces durable immunity in >95% of healthy infants. A blood test (anti-HBs) can confirm protection if you are now in a higher-risk role (healthcare, multiple partners). A booster is offered if titres are low.

  2. Can hepatitis B be cured?

    Acute HBV resolves in around 95% of healthy adults without treatment. Chronic HBV (in 5% of adults, much higher in infants) can usually be controlled but rarely eradicated with current antivirals - long-term suppression prevents cirrhosis and liver cancer.

  3. Should my partner get tested and vaccinated?

    Yes. All sexual and household contacts of someone with HBV should be tested. Non-immune contacts should be vaccinated and, for recent significant exposure, given hepatitis B immunoglobulin within 72 hours.

  4. What is the post-exposure plan if I have a needlestick or unprotected sex with an HBV-positive partner?

    If non-immune, start the HBV vaccine series and give a single dose of HBIG ideally within 24 hours, no later than 72 hours. We arrange this same-day.

  5. Is hepatitis A also an STI?

    Hepatitis A is not classically an STI but can be transmitted through oral-anal sexual contact and has caused outbreaks among MSM. Hepatitis A vaccine is recommended for MSM and people with chronic HBV/HCV.

  6. How is HBV care arranged at Hisential?

    Your personal health concierge coordinates testing, vaccination, post-exposure prophylaxis and - for chronic HBV - shared monitoring with a hepatologist in one confidential pathway.

Still have a question?

Your Personal Concierge replies within one business day - confidentially.

References

Other STI conditions

Browse our other in-depth STI guides - each covers symptoms, asymptomatic statistics by sex, Malaysia data, testing windows, treatment and prevention.

See all STI conditions →

Your personal health concierge

One dedicated contact coordinates your testing, treatment, partner support and follow-up - discreetly and end-to-end. All care is delivered by our MMC-registered medical team.

Book a confidential appointment